Predicting the cause of brief double vision episodes
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial looks at a way to predict what causes short-lasting double vision. It may help doctors choose the right next steps faster after symptoms stop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an episode of double vision that went away within 24 hours
- Your double vision episode happened within the last 8 days
- You must be able to share details about the episode with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses eye movement tests to help doctors tell apart different causes of sudden dizziness or vertigo. It may help improve diagnosis and treatment for people with acute vestibular syndrome.
This study tracks people who have brief episodes of vertigo or dizziness that may be caused by temporary reduced blood flow to the back of the brain. The goal is to better understand these episodes and improve diagnosis and treatment.
This trial tests ways to improve control of intermittent exotropia, a type of eye misalignment that comes and goes, without surgery for at least 6 months.
This study tests a new way to reduce 'ghosting'—double or shadow images—that some people see, especially with astigmatism or at night. It involves using a special visual test to measure and possibly correct this effect.
This trial tests a visual therapy program designed to improve eye alignment in people with intermittent strabismus (when the eyes sometimes drift). It involves 12 in-office sessions and may help reduce the frequency of eye turning.
This trial tests a new treatment for children aged 8 to 12 with lazy eye (amblyopia) who have stopped standard treatments. The goal is to see if this therapy can improve vision in the weaker eye.
Hear when a new Diplopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.